Posts
- Category: important (continued)
- Huntington's Disease Therapeutics Conference 2016 - day 3
- Huntington’s Disease Protein Helps Wire the Young Brain
- Huntington’s research results in treatment advance
- Huntington’s therapy discovered at Stanford shows positive results in humans
- IBM Researchers' New Approach To Huntington's Could Lead To Significant Breakthrough In Therapy
- Il futuro del trattamento della Malattia di Huntington
- Indian Researchers Find Insulin Clue to Huntington’s Disease
- Ionis Pharmaceuticals Licenses IONIS-HTT Rx to Partner Following Successful Phase 1/2a Study in Patients with Huntington's Disease
- Ionis Pharmaceuticals Receives Orphan Drug Designation from the US FDA for IONIS-HTT Rx for the Treatment of Patients with Huntington's Disease
- IONIS-HTT Rx (RG6042) Top-Line Data Demonstrate Significant Reductions of Disease-Causing Mutant Huntingtin Protein in People with Huntington's Disease
- Is genetic testing humans playing God?
- Isis Pharmaceuticals Initiates Clinical Study of ISIS-HTT Rx in Patients With Huntington's Disease
- IXICO awarded two further contracts in Huntington's disease
- Jackson Laboratory researchers find new mechanism for neurodegeneration
- Jumping genes: Huntington's disease protein invades brain transplants
- LA DIAGNOSI PREIMPIANTO PER MALATTIE GENETICHE: LA SPERANZA CHE LA CORTE COSTITUZIONALE FACCIA CADERE IL DIVIETO IMPOSTO DALLA LEGGE 40
- La scienza ci salverà
- La tetrabenazina nella terapia dei movimenti coreici: il punto di vista di Jo Jankovic
- Landmark Huntington's trial starts
- Major Wellcome Trust award to UCL boosts Huntington’s disease research
- Malattia di Huntington, la trieptanoina migliora il metabolismo energetico del cervello
- MedStar Georgetown Offers First U.S. Program for Young People Impacted by Huntington Disease
- Meet the little girl who’s been 'designed' to help beat Huntington’s disease
- Melatonin alterations in Huntington's disease help explain trouble with sleep
- Moving toward a potential treatment: Isis, CHDI researchers outline upcoming Huntington’s disease gene-silencing trial
- Mutant Protein Spreads Through a Neural Circuit in Huntington’s Disease
- New Data from IONIS-HTT Rx Phase 1/2 Study Demonstrates Correlation Between Reduction of Disease-causing Protein and Improvement in Clinical Measures of Huntington's Disease
- New discovery is a step towards developing Huntington’s disease treatments before symptoms appear
- New Evidence: How Amino Acid Cysteine Combats Huntington’s Disease
- New insight into Huntington’s disease may open door to drug development
- New study offers hope for Huntington’s Disease patients
- New study reveals a potential HD biomarker
- News flash: Isis and Roche hope to start Huntington’s gene-silencing trial in first half of 2015
- NOTIZIARIO AICH - ROMA APRILE 2014
- NOTIZIARIO AICH – ROMA AGOSTO 2014
- Novel RNAi Therapy Silences Mutated Huntington's Disease Gene and Reduces Symptoms
- Novità per la cura della malattia di Huntington
- NUB1: enhancing clearance to decrease mutant huntingtin
- ORNL, UTGSM study compares structures of Huntington’s disease protein
- PBT2 recommended for orphan designation in Europe
- Pitt Study Shows for First Time How Huntington’s Disease Protein Could Cause Death of Neurons
- Possible new treatment for neurodegenerative diseases found
- Potential new treatments for depression uncovered by research into Huntington's
- Potential Therapeutic Target for Huntington’s Disease
- Potential Treatment for Huntington's Disease, Found Effective, Safe in Mice, Monkeys, Enters Clinical Testing
- Prana receives FDA Orphan Drug Designation for PBT2 for Huntington Disease
- Prana's PBT2 receives FDA Orphan Drug designation for treatment of Huntington diseaseread more
- PRIME designation granted by European Medicines Agency for RG6042 for treatment of Huntington’s disease
- Progress at the Scientific Planning Committee
- Promising approach to slow brain degeneration in a model of Huntington's disease uncovered
Plugin by dagondesign.com
